Skip to main content
Robert Wood Johnson Foundation
  • Our Vision
    • Our Vision Overview
    • Why Health Equity
    • Focus Areas
    • Measuring RWJF Progress
  • Grants
    • Grants Overview
    • Active Funding Opportunities
    • Awarded Grants
    • Grantee Stories
    • Grant Process
    • Grantee Resources
  • Insights
    • Insights Overview
    • Blog
    • Our Research
    • Advocacy And Policy
  • About RWJF
    • About RWJF Overview
    • Our Guiding Principles
    • How We Work
    • Impact Investments
    • Staff And Trustees
    • Press Room
    • Careers
    • Contact Us
    • Accessibility Statement
Find A Grant
Global Search Dialog
    Robert Wood Johnson Foundation
    • Our Vision
      • Our Vision Overview
      • Why Health Equity
      • Focus Areas
      • Measuring RWJF Progress
    • Grants
      • Grants Overview
      • Active Funding Opportunities
      • Awarded Grants
      • Grantee Stories
      • Grant Process
      • Grantee Resources
    • Insights
      • Insights Overview
      • Blog
      • Our Research
      • Advocacy And Policy
    • About RWJF
      • About RWJF Overview
      • Our Guiding Principles
      • How We Work
      • Impact Investments
      • Staff And Trustees
      • Press Room
      • Careers
      • Contact Us
      • Accessibility Statement
    Find A Grant
    Global Search Dialog

      Using AD Biomarker Research Results for Clinical Care

      Brief Aug-21-2013 | Shulman MB, Harkins K, Green RC, Karlawish J | 1-min read
      1. Insights
      2. Our Research
      3. Using AD Biomarker Research Results for Clinical Care
      Read article
      Games for Health

       

      This article examines investigators' opinions on changing the Alzheimer’s Disease Neuroimaging Initiative (ADNI) policy and disclosing ADNI biomarker information to research participants.

       

      The Issue

      The Alzheimer’s Disease Neuroimaging Initiative (ADNI) gathers medical data researchers use for clinical research. Currently, ADNI policy states that research results not be returned to ADNI participants. In April 2012, the Food and Drug Administration (FDA) approved the amyloid-binding radiotracer florbetapir. Given this approval, this article examines investigators' opinions on changing the ADNI policy and disclosing ADNI biomarker information to research participants.

      While a majority support disclosure of amyloid, ADNI investigators need guidance on how to return results and monitor the disclosure process.

       

      Key Findings


       

      • Among ADNI investigators, 90 percent do not return amyloid imaging results to ADNI participants.

         

      • Seventy-three percent of ANDI researchers overall definitely or probably support disclosure of amyloid imaging information to participants with mild cognitive impairment.

         

      • However, 58 percent definitely or probably support disclosure to participants with normal cognition.

         

      Conclusion

      Current guidelines for returning research results in genomic studies often focuses on protecting patients, but trends are changing. The findings above suggest that ADNI policy may first want to address those with mild cognitive impairment. ADNI investigators need guidance on how to return results and monitor the disclosure process. Additionally, research is required on understanding the value of returning results. This study provides important information as ADNI assesses its policy.

       

      About the Study

      All ADNI investigators and personnel were invited to complete an anonymous online survey. Questions were both fixed choice and free-text questions. Data collection took place between March 2012 and April 2012. A total of 159 individuals responded (52% overall response rate).

      Subscribe to receive Funding Alerts & more

      Explore the latest in reflection and research from subject matter experts at RWJF and our wide network of partners.

      Email address already subscribed. Please check your inbox to manage your subscriptions.

      Subscribed!

      Thank you. You are now subscribed.

      Tell us what type of content you want to receive.

      Be informed with our twice a month newsletter updating you with relevant news and research around a Culture of Health, as well as the latest funding opportunities.

      Get funded by RWJF: Receive notifications when new funding opportunities are released.

      Receive monthly updates on RWJF-sponsored research that informs many robust health policy debates on Capitol Hill, covering topics like health equity, improving access to quality healthcare, equitable housing, and more.

      Shop talk for researchers. This monthly newsletter covers research news and opportunities from the Robert Wood Johnson Foundation.

      Communications expedite action. Get periodic research and expert insights on the best ways to communicate so we can spread what works.

      Sometimes we have news, announcements or opportunities that don't quite fit the subscription parameters above. If you're interested, we'll send you this information under "There's more...". *If you've indicated you are an EU resident, we will only send these communications if you intentionally check this box.

      Which profession or pursuit best describes you?

      Area(s) Of Interest

      Unsubscribe

      Stop receiving all emails from RWJF

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
      • CONTACT RWJF

        50 College Road East
        Princeton, NJ 08540-6614

         

        US Toll Free: (877) 843-7953

        International: +1 (609) 627-6000

      • MANAGE YOUR GRANTS

        MyRWJF Login

        • Facebook
        • LinkedIn
        • YouTube
        • Instagram

      • Our Vision
        • Our Vision Overview
        • Why Health Equity
        • Focus Areas
        • Measuring RWJF Progress
      • Grants
        • Grants Overview
        • Active Funding Opportunities
        • Awarded Grants
        • Grantee Stories
        • Grant Process
        • Grantee Resources
      • Insights
        • Insights Overview
        • Blog
        • Our Research
        • Advocacy And Policy
      • About RWJF
        • About RWJF Overview
        • Our Guiding Principles
        • How We Work
        • Impact Investments
        • Staff And Trustees
        • Press Room
        • Careers
        • Contact Us
        • Accessibility Statement

      ©2001- 

      Robert Wood Johnson Foundation. All Rights Reserved. 

       

      • Manage Email
      • Privacy Statement
      • Terms and Conditions